JoVE Logo
Faculty Resource Center

Sign In

Summary

Abstract

Introduction

Protocol

Representative Results

Discussion

Acknowledgements

Materials

References

Behavior

The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice

Published: October 24th, 2018

DOI:

10.3791/58184

1School of Behavioral Science, The Academic College Tel-Aviv-Yaffo, 2Department of Education and Psychology, Open University

Here we present the unpredictable chronic mild stress protocol in mice. This protocol induces a long-term depressive-like phenotype and enables to assess the efficacy of putative antidepressants in reversing the behavioral and neuromolecular depressive-like deficits.

Depression is a highly prevalent and debilitating condition, only partially addressed by current pharmacotherapies. The lack of response to treatment by many patients prompts the need to develop new therapeutic alternatives and to better understand the etiology of the disorder. Pre-clinical models with translational merits are rudimentary for this task. Here we present a protocol for the unpredictable chronic mild stress (UCMS) method in mice. In this protocol, adolescent mice are chronically exposed to interchanging unpredictable mild stressors. Resembling the pathogenesis of depression in humans, stress exposure during the sensitive period of mice adolescence instigates a depressive-like phenotype evident in adulthood. UCMS can be used for screenings of antidepressants on the variety of depressive-like behaviors and neuromolecular indices. Among the more prominent tests to assess depressive-like behavior in rodents is the sucrose preference test (SPT), which reflects anhedonia (core symptom of depression). The SPT will also be presented in this protocol. The ability of UCMS to induce anhedonia, instigate long-term behavioral deficits and enable reversal of these deficits via chronic (but not acute) treatment with antidepressants strengthens the protocol's validity compared to other animal protocols for inducing depressive-like behaviors.

Major depressive disorder (MDD) is a debilitating condition, that has been indicated as the 11th cause of global burden from disease1, with a lifetime prevalence of 11–16%2,3. MDD has been associated with severe impairments on patients' social and occupational functioning, diminished quality of life, numerous mental and physical disorders and increased risk for mortality4,5,6,7. There are several efficacious pharmacotherapies and psycholog....

Log in or to access full content. Learn more about your institution’s access to JoVE content here

All methods described here have been approved by the Institutional Animal Care and Use Committee of the Academic College Tel-Aviv-Yaffo.

1. Animals

  1. Use pre-adolescent (i.e., 3 weeks old) Institute of Cancer Research (ICR) outbred male mice.
  2. Randomize mice to two equally sized stress group (UCMS vs. naïve). Use 15 mice per treatment group (e.g.: if there are 3 pharmacological treatment groups use 90 mice overall; 2 [UCMS vs. naïve] × 3 [tre.......

Log in or to access full content. Learn more about your institution’s access to JoVE content here

In order to corroborate the efficacy of the UCMS procedure for inducing depressive-like deficits, a manipulation check was conducted. Male ICR outbred mice were randomly assigned to either UCMS or naïve conditions (4 weeks, as described in protocol 2.2). Subsequently, the SPT (6 days, as described in protocol 4) was administered to assess whether mice after undergoing UCMS demonstrated hedonic deficits. Shortly after, mice were sacrificed and the hippocampus was dissected o.......

Log in or to access full content. Learn more about your institution’s access to JoVE content here

Insofar as MDD is a widespread highly debilitating disorder, only partially addressed by current therapeutic options, the scientific quest for better treatments is still a pressing issue. Along with innovations in psychological techniques, additional pharmacotherapies are required for the large portion of patients who do not respond to the existing drugs. Meticulous animal models for depression are the key element in this task. Such models facilitate screenings for innovative antidepressants and expand the understanding .......

Log in or to access full content. Learn more about your institution’s access to JoVE content here

The authors would like to thank Gali Breuer for her assistance in the video production. This research was supported by the Israel Ministry of Science, Technology & Space (grant no. 313552), by the National Institute for Psychobiology in Israel (NIPI-208-16-17b) and by the Open University Foundation.

....

Log in or to access full content. Learn more about your institution’s access to JoVE content here

Name Company Catalog Number Comments
Heating lamp Ikea AA-19025-3
Heating pillow Sachs EF-188B
Mice restrainer
Portable electronic balance (*.** g)
Standard rubber stopper, size 5 Ancare #5.5R To avoid spillage during SPT
Straight open drinking tube (2.5") Ancare OT-100 To avoid spillage during SPT (insert drinking tube into rubber stopper)
2% sucrose solution
50ml conical centrifuge tube For the SPT
Pre-adolescent (approximately 20-days old) ICR outbred mice Envigo Hsd:ICR (CD-1)

  1. Murray, C. J., et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study. Lancet. 380 (9859), 2197-2223 (2010).
  2. Bromet, E., et al. Cross-national epidemiology of DSM-IV major depressive episode. BMC Medicine. 9, (2011).
  3. Kessler, R. C., et al. The Epidemiology of Major Depressive Disorder. JAMA: The Journal of the American Medical Association. 289 (23), 3095 (2003).
  4. Doom, J. R., Haeffel, G. J. Teasing apart the effects of cognition, stress, and depression on health. American Journal of Health Behavior. 37 (5), 610-619 (2013).
  5. Mykletun, A., Bjerkeset, O., Øverland, S., Prince, M., Dewey, M., Stewart, R. Levels of anxiety and depression as predictors of mortality: The HUNT study. British Journal of Psychiatry. 195 (2), 118-125 (2009).
  6. Moussavi, S., Chatterji, S., Verdes, E., Tandon, A., Patel, V., Ustun, B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet. 370 (9590), 851-858 (2007).
  7. Otte, C., et al. Major depressive disorder. Nature Reviews Disease Primers. 2, (2016).
  8. Rush, A. J., et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report. Amerian Journal of Psychiatry. 163 (11), 1905-1917 (2006).
  9. Cuijpers, P., Karyotaki, E., Weitz, E., Andersson, G., Hollon, S. D., Van Straten, A. The effects of psychotherapies for major depression in adults on remission, recovery and improvement: A meta-analysis. Journal of Affective Disorder. 159, 118-126 (2014).
  10. Lam, R. W., et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder. Canadian Journal of Psychiatry. 61 (9), 510-523 (2016).
  11. Kupfer, D. J., Frank, E., Phillips, M. L. Major depressive disorder: New clinical, neurobiological, and treatment perspectives. Lancet. 379 (9820), 1045-1055 (2012).
  12. Willner, P. Chronic mild stress (CMS) revisited: Consistency and behavioural- neurobiological concordance in the effects of CMS. Neuropsychobiology. 52 (2), 90-110 (2005).
  13. Surget, A., Belzung, C. Unpredictable chronic mild stress in mice. Experimental Animal Model in Neurobehavior Research. , 79-112 (2009).
  14. Hoffman, K. L. 2 -What can animal models tell us about depressive disorders?. Modelling Neuropsychiatric Disorder in Laboratory Animals. , (2016).
  15. Cryan, J. F., Holmes, A. The ascent of mouse: advances in modelling human depression and anxiety. Nature Review Drug Discovery. 4 (9), 775-790 (2005).
  16. Katz, R. J., Roth, K. A., Carroll, B. J. Acute and chronic stress effects on open field activity in the rat: Implications for a model of depression. Neuroscience and Biobehavior Reviews. 5 (2), 247-251 (1981).
  17. Willner, P. The validity of animal models of depression. Psychopharmacology (Berlin). 83 (1), 1-16 (1984).
  18. Willner, P., Towell, A., Sampson, D., Sophokleous, S., Muscat, R. Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology (Berlin). 93 (3), 358-364 (1987).
  19. Ducottet, C., Belzung, C. Behaviour in the elevated plus-maze predicts coping after subchronic mild stress in mice. Physiology and Behavior. 81 (3), 417-426 (2004).
  20. Treadway, M. T., Zald, D. H. Reconsidering anhedonia in depression: Lessons from translational neuroscience. Neuroscience and Biobehavioral Reviews. 35 (3), 537-555 (2011).
  21. Pothion, S., Bizot, J. C., Trovero, F., Belzung, C. Strain differences in sucrose preference and in the consequences of unpredictable chronic mild stress. Behavioural Brain Research. 155 (1), 135-146 (2004).
  22. American Psychiatric Association. . Diagnostic and Statistical Manual of Mental Disorders. 5th Edition (DSM-5). , (2013).
  23. Pizzagalli, D. A. Depression, stress, and anhedonia: toward a synthesis and integrated model. Annual Review Clinical Psychology. 10, 393-423 (2014).
  24. Nollet, M., Le Guisquet, A. -. M., Belzung, C. Models of depression: unpredictable chronic mild stress in mice. Current Protocols in Pharmacology. , (2013).
  25. Doron, R., Lotan, D., Rak-Rabl, A., Raskin-Ramot, A., Lavi, K., Rehavi, M. Anxiolytic effects of a novel herbal treatment in mice models of anxiety. Life Science. 90 (25-26), 995-1000 (2012).
  26. Rössler, A. S., Joubert, C., Chapouthier, G. Chronic mild stress alleviates anxious behaviour in female mice in two situations. Behavioural Processes. 49 (3), 163-165 (2000).
  27. Maslova, L. N., Bulygina, V. V., Markel, A. L. Chronic stress during prepubertal development: Immediate and long-lasting effects on arterial blood pressure and anxiety-related behavior. Psychoneuroendocrinology. 27 (5), 549-561 (2002).
  28. Zhu, S., Shi, R., Wang, J., Wang, J. -. F., Li, X. -. M. Unpredictable chronic mild stress not chronic restraint stress induces depressive behaviours in mice. Neuroreport. 25 (14), 1151-1155 (2014).
  29. Bondi, C. O., Rodriguez, G., Gould, G. G., Frazer, A., Morilak, D. A. Chronic unpredictable stress induces a cognitive deficit and anxiety-like behavior in rats that is prevented by chronic antidepressant drug treatment. Neuropsychopharmacology. 33 (2), 320-331 (2008).
  30. Burstein, O., et al. Escitalopram and NHT normalized stress-induced anhedonia and molecular neuroadaptations in a mouse model of depression. PLoS One. 12 (11), (2017).
  31. Willner, P., Muscat, R., Papp, M. Chronic mild stress-induced anhedonia: A realistic animal model of depression. Neuroscience and Biobehavioral Reviews. 16 (4), 525-534 (1992).
  32. Papp, M., Willner, P., Muscat, R. An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress. Psychopharmacology (Berlin). 104 (2), 255-259 (1991).
  33. Kumar, B., Kuhad, A., Chopra, K. Neuropsychopharmacological effect of sesamol in unpredictable chronic mild stress model of depression: Behavioral and biochemical evidences. Psychopharmacology (Berlin). 214 (4), 819-828 (2011).
  34. Mineur, Y. S., Belzung, C., Crusio, W. E. Effects of unpredictable chronic mild stress on anxiety and depression-like behavior in mice. Behavioral Brain Research. 175 (1), 43-50 (2006).
  35. Ibarguen-Vargas, Y., et al. Deficit in BDNF does not increase vulnerability to stress but dampens antidepressant-like effects in the unpredictable chronic mild stress. Behavioral Brain Research. 202 (2), 245-251 (2009).
  36. Luo, D. D., An, S. C., Zhang, X. Involvement of hippocampal serotonin and neuropeptide Y in depression induced by chronic unpredicted mild stress. Brain Research Bulletin. 77 (1), 8-12 (2008).
  37. Bhutani, M. K., Bishnoi, M., Kulkarni, S. K. Anti-depressant like effect of curcumin and its combination with piperine in unpredictable chronic stress-induced behavioral, biochemical and neurochemical changes. Pharmacolology and Biochemistry Behavior. 92 (1), 39-43 (2009).
  38. Lin, Y. H., Liu, A. H., Xu, Y., Tie, L., Yu, H. M., Li, X. J. Effect of chronic unpredictable mild stress on brain-pancreas relative protein in rat brain and pancreas. Behavior Brain Research. 165 (1), 63-71 (2005).
  39. Cox, B. M., Alsawah, F., McNeill, P. C., Galloway, M. P., Perrine, S. A. Neurochemical, hormonal, and behavioral effects of chronic unpredictable stress in the rat. Behavior Brain Research. 220 (1), 106-111 (2011).
  40. Lagunas, N., Calmarza-Font, I., Diz-Chaves, Y., Garcia-Segura, L. M. Long-term ovariectomy enhances anxiety and depressive-like behaviors in mice submitted to chronic unpredictable stress. Hormones and Behavior. 58 (5), 786-791 (2010).
  41. Papp, M., Klimek, V., Willner, P. Parallel changes in dopamine D2 receptor binding in limbic forebrain associated with chronic mild stress-induced anhedonia and its reversal by imipramine. Psychopharmacology (Berlin). 115 (4), 441-446 (1994).
  42. Harkin, A., Houlihan, D. D., Kelly, J. P. Reduction in preference for saccharin by repeated unpredictable stress in mice and its prevention by imipramine. Journal of Psychopharmacology. 16 (2), 115-123 (2002).
  43. Detanico, B. C., et al. Antidepressant-like effects of melatonin in the mouse chronic mild stress model. European Journal of Pharmacology. 607 (1-3), 121-125 (2009).
  44. Kubera, M., et al. Prolonged desipramine treatment increases the production of interleukin-10, an anti-inflammatory cytokine, in C57BL/6 mice subjected to the chronic mild stress model of depression. Journal of Affective Disorder. 63 (1-3), 171-178 (2001).
  45. Moreau, J. L., Jenck, F., Martin, J. R., Mortas, P., Haefely, W. E. Antidepressant treatment prevents chronic unpredictable mild stress-induced anhedonia as assessed by ventral tegmentum self-stimulation behavior in rats. European Neuropsychopharmacoly. 2 (1), 43-49 (1992).
  46. Muscat, R., Papp, M., Willner, P. Reversal of stress-induced anhedonia by the atypical antidepressants, fluoxetine and maprotiline. Psychopharmacology (Berlin). 109 (4), 433-438 (1992).
  47. Yalcin, I., Belzung, C., Surget, A. Mouse strain differences in the unpredictable chronic mild stress: a four-antidepressant survey. Behavioural Brain Research. 193 (1), 140-143 (2008).
  48. Moreau, J. L., Bourson, A., Jenck, F., Martin, J. R., Mortas, P. Curative effects of the atypical antidepressant mianserin in the chronic mild stress-induced anhedonia model of depression. Journal of Psychiatry Neuroscience. 19 (1), 51-56 (1994).
  49. Kopp, C., Vogel, E., Rettori, M. C., Delagrange, P., Misslin, R. The effects of melatonin on the behavioural disturbances induced by chronic mild stress in C3H/He mice. Behavioural Pharmacology. 10 (1), 73-83 (1999).
  50. Doron, R., et al. Escitalopram or novel herbal mixture treatments during or following exposure to stress reduce anxiety-like behavior through corticosterone and BDNF modifications. PLoS One. 9 (4), (2014).
  51. Elizalde, N., et al. Long-lasting behavioral effects and recognition memory deficit induced by chronic mild stress in mice: Effect of antidepressant treatment. Psychopharmacology (Berlin). 199 (1), 1-14 (2008).
  52. Casarotto, P. C., Andreatini, R. Repeated paroxetine treatment reverses anhedonia induced in rats by chronic mild stress or dexamethasone. European Neuropsychopharmacology. 17 (11), 735-742 (2007).
  53. Papp, M., Gruca, P., Boyer, P. -. A., Mocaër, E. Effect of agomelatine in the chronic mild stress model of depression in the rat. Neuropsychopharmacology. 28 (4), 694-703 (2003).
  54. Bortolato, M., et al. Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress. Biological Psychiatry. 62 (10), (2007).
  55. Liu, Y., et al. Antidepressant-like effects of tea polyphenols on mouse model of chronic unpredictable mild stress. Pharmacology Biochemistry Behavior. 104 (1), 27-32 (2013).
  56. Dai, Y., et al. Metabolomics study on the anti-depression effect of xiaoyaosan on rat model of chronic unpredictable mild stress. Journal of Ethnopharmacology. 128 (2), 482-489 (2010).
  57. Zhang, D., Wen, X. S., Wang, X. Y., Shi, M., Zhao, Y. Antidepressant effect of Shudihuang on mice exposed to unpredictable chronic mild stress. Jouranl of Ethnopharmacology. 123 (1), 55-60 (2009).
  58. Li, Y. C., et al. Antidepressant-like effects of curcumin on serotonergic receptor-coupled AC-cAMP pathway in chronic unpredictable mild stress of rats. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 33 (3), 435-449 (2009).
  59. Monleon, S., Parra, A., Simon, V. M., Brain, P. F., D'Aquila, P., Willner, P. Attenuation of sucrose consumption in mice by chronic mild stress and its restoration by imipramine. Psychopharmacology (Berlin). 117 (4), 453-457 (1995).
  60. Papp, M., Moryl, E., Willner, P. Pharmacological validation of the chronic mild stress model of depression. European Journal of Pharmacology. 296 (2), 129-136 (1996).
  61. Jansen, K., et al. Childhood trauma, family history, and their association with mood disorders in early adulthood. Acta Psychiatrica Scandinavica. (4), (2016).
  62. Kessler, R. C. THE EFFECTS OF STRESSFUL LIFE EVENTS ON DEPRESSION. Annual Review of Psychology. 48 (1), 191-214 (1997).
  63. Brady, K. T., Back, S. E. Childhood trauma, posttraumatic stress disorder, and alcohol dependence. Alcohol Research. 34 (4), 408-413 (2012).
  64. Pariante, C. M., Lightman, S. L. The HPA axis in major depression: classical theories and new developments. Trends in Neurosciences. 31 (9), 464-468 (2008).
  65. De Bellis, M. D., et al. Developmental traumatology part I: biological stress systems. Biological Psychiatry. 45 (10), 1259-1270 (1999).
  66. de Kloet, E. R., Joëls, M., Holsboer, F. Stress and the brain: from adaptation to disease. Nature Reviews Neurosciences. 6 (6), 463-475 (2005).
  67. Heim, C., Newport, D. J., Mletzko, T., Miller, A. H., Nemeroff, C. B. The link between childhood trauma and depression: Insights from HPA axis studies in humans. Psychoneuroendocrinology. 33 (6), 693-710 (2008).
  68. Trickett, P. K., Noll, J. G., Susman, E. J., Shenk, C. E., Putnam, F. W. Attentuation of cortisol across development for victims of sexual abuse. Developmental Psychopathology. 22 (1), 165-175 (2010).
  69. Bremne, J. D., Vermetten, E. Stress and development: behavioral and biological consequences. Developmental Psychopathology. 13 (3), 473-489 (2001).
  70. Nestler, E. J., Barrot, M., DiLeone, R. J., Eisch, A. J., Gold, S. J., Monteggia, L. M. Neurobiology of depression. Neuron. 34 (1), 13-25 (2002).
  71. Liu, D., et al. Resveratrol reverses the effects of chronic unpredictable mild stress on behavior, serum corticosterone levels and BDNF expression in rats. Behavioural and Brain Research. 264, 9-16 (2014).
  72. Silberman, D. M., Wald, M., Genaro, A. M. Effects of chronic mild stress on lymphocyte proliferative response. Participation of serum thyroid hormones and corticosterone. Int Immunopharmacol. 2 (4), 487-497 (2002).
  73. Bielajew, C., Konkle, A. T., Merali, Z. The effects of chronic mild stress on male Sprague-Dawley and Long Evans rats: I. Biochemical and physiological analyses. Behavioural and Brain Research. 136 (2), 583-592 (2002).
  74. Vrieze, E., et al. Dimensions in major depressive disorder and their relevance for treatment outcome. Journal of Affective Disorder. 155 (1), 35-41 (2014).
  75. Doron, R., et al. A novel herbal treatment reduces depressive-like behaviors and increases BDNF levels in the brain of stressed mice. Life Sciences. 94 (2), 151-157 (2014).
  76. Nestler, E. J., Hyman, S. E. Animal models of neuropsychiatric disorders. Nature Neurosciences. 13 (10), 1161-1169 (2010).
  77. Yan, H. -. C., Cao, X., Das, M., Zhu, X. -. H., Gao, T. -. M. Behavioral animal models of depression. Neuroscience Bulletin. 26 (4), 327-337 (2010).
  78. Yankelevitch-Yahav, R., Franko, M., Huly, A., Doron, R. The Forced Swim Test as a Model of Depressive-like Behavior. Journal of Visualized Experiment. (97), (2015).
  79. Cryan, J. F., Mombereau, C., Vassout, A. The tail suspension test as a model for assessing antidepressant activity: Review of pharmacological and genetic studies in mice. Neurosciences and Biobehavioral Reviews. 29 (4-5), 571-625 (2005).
  80. Berton, O., et al. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science. 80 (5762), 864-868 (2006).
  81. Krishnan, V., Nestler, E. J. Animal models of depression: Molecular perspectives. Current Topics in Behavioral Neurosciences. 7 (1), 121-147 (2011).
  82. Belzung, C., Lemoine, M. Criteria of validity for animal models of psychiatric disorders: focus on anxiety disorders and depression. Biology of Mood and Anxiety Disorder. 1 (1), 9 (2011).
  83. Björkqvist, K. Social defeat as a stressor in humans. Physiology and Behavior. 73 (3), 435-442 (2001).
  84. Parihar, V. K., Hattiangady, B., Kuruba, R., Shuai, B., Shetty, A. K. Predictable chronic mild stress improves mood, hippocampal neurogenesis and memory. Molecular Psychiatry. 16 (2), 171-183 (2011).
  85. Haile, C. N., GrandPre, T., Kosten, T. A. Chronic unpredictable stress, but not chronic predictable stress, enhances the sensitivity to the behavioral effects of cocaine in rats. Psychopharmacology (Berlin). 154 (2), 213-220 (2001).
  86. Suo, L., et al. Predictable chronic mild stress in adolescence increases resilience in adulthood. Neuropsychopharmacology. 38 (8), 1387-1400 (2013).
  87. Gameiro, G. H., et al. Nociception- and anxiety-like behavior in rats submitted to different periods of restraint stress. Physiology and Behavior. 87 (4), 643-649 (2006).
  88. Anisman, H., Matheson, K. Stress, depression, and anhedonia: Caveats concerning animal models. Neuroscience and Biobehavioural Reviews. 29 (4-5), 525-546 (2005).
  89. Carr, W. J., Martorano, R. D., Krames, L. Responses of mice to odors associated with stress. J Comp Physiol Psychol. 71, 223-228 (1970).
  90. Zalaquett, C., Thiessen, D. The effects of odors from stressed mice on conspecific behavior. Physiology and Behavior. 50 (1), 221-227 (1991).
  91. Burstein, O., Shoshan, N., Doron, R., Akirav, I. Cannabinoids prevent depressive-like symptoms and alterations in BDNF expression in a rat model of PTSD. Progess in Neuro-Psychopharmacology Biological psychiatry. 84 (Part A), 129-139 (2018).
  92. Hedrich, H. J., Nicklas, W. Housing and Maintenance. Lab Mouse. , 521-545 (2012).
  93. Molendijk, M. L., Spinhoven, P., Polak, M., Bus, B. A. A., Penninx, B. W. J. H., Elzinga, B. M. Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484). Molecular Psychiatry. 19 (7), 791-800 (2014).
  94. Chen, B., Dowlatshahi, D., MacQueen, G. M., Wang, J. F., Young, L. T. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biological Psychiatry. 50 (4), 260-265 (2001).
  95. Tye, K. M., et al. Dopamine neurons modulate neural encoding and expression of depression-related behaviour. Nature. 493 (7433), 537-541 (2013).
  96. Hamani, C., et al. Deep brain stimulation reverses anhedonic-like behavior in a chronic model of depression: Role of serotonin and brain derived neurotrophic factor. Biological Psychiatry. 71 (1), 30-35 (2012).
  97. Hill, M. N., Hellemans, K. G. C., Verma, P., Gorzalka, B. B., Weinberg, J. Neurobiology of chronic mild stress: Parallels to major depression. Neuroscience and Biobehavior Reviews. 36 (9), 2085-2117 (2012).
  98. Kasch, K. L., Rottenberg, J., Ba Arnow, ., Gotlib, I. H. Behavioral activation and inhibition systems and the severity and course of depression. Journal of Abnormal Psychology. 111 (4), 589-597 (2002).
  99. Faull, J. R., Halpern, B. P. Reduction of sucrose preference in the hamster by gymnemic acid. Physiology and Behavior. 7 (6), 903-907 (1971).
  100. Moreau, J. -. L., Scherschlicht, R., Jenck, F., Martin, J. R. Chronic mild stress-induced anhedonia model of depression; sleep abnormalities and curative effects of electroshock treatment. Behavioural Pharmacology. 6 (7), 682-687 (1995).
  101. Blier, P. Optimal use of antidepressants: when to act?. J Psychiatry Neurosci. 34 (1), 80 (2009).
  102. Frazer, A., Benmansour, S. Delayed pharmacological effects of antidepressants. Mol Psychiatry. 7, S23-S28 (2002).
  103. Can, A., Dao, D. T., Terrillion, C. E., Piantadosi, S. C., Bhat, S., Gould, T. D. The Tail Suspension Test. Journal of Visualized Experiments. (58), (2011).
  104. Song, L., Che, W., Min-wei, W., Murakami, Y., Matsumoto, K. Impairment of the spatial learning and memory induced by learned helplessness and chronic mild stress. Pharmacology Biochemistry and Behavior. 83 (2), 186-193 (2006).
  105. Mao, Q. Q., Ip, S. P., Ko, K. M., Tsai, S. H., Che, C. T. Peony glycosides produce antidepressant-like action in mice exposed to chronic unpredictable mild stress: Effects on hypothalamic-pituitary-adrenal function and brain-derived neurotrophic factor. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 33 (7), 1211-1216 (2009).
  106. Lutz, C. M., Linder, C. C., Davisson, M. T. Strains, Stocks and Mutant Mice. Lab Mouse. , 37-56 (2012).
  107. Yalcin, I., Aksu, F., Belzung, C. Effects of desipramine and tramadol in a chronic mild stress model in mice are altered by yohimbine but not by pindolol. European Journal of Pharmacology. 514 (2-3), 165-174 (2005).
  108. Van Boxelaere, M., Clements, J., Callaerts, P., D'Hooge, R., Callaerts-Vegh, Z. Unpredictable chronic mild stress differentially impairs social and contextual discrimination learning in two inbred mouse strains. PLoS One. 12 (11), (2017).
  109. Nadler, J. J., et al. Automated apparatus for quantitation of social approach behaviors in mice. Genes, Brain Behavior. 3 (5), 303-314 (2004).
  110. Girard, I., Garland, T. Plasma corticosterone response to acute and chronic voluntary exercise in female house mice. Journal of Applied Physiology. 92 (4), 1553-1561 (2002).
  111. Gumuslu, E., et al. The antidepressant agomelatine improves memory deterioration and upregulates CREB and BDNF gene expression levels in unpredictable chronic mild stress (UCMS)-exposed mice. Drug Target Insights. 2014 (8), 11-21 (2014).
  112. Willner, P., Golembiowska, K., Klimek, V., Muscat, R. Changes in mesolimbic dopamine may explain stress-induced anhedonia. Psychobiology. 19 (1), 79-84 (1991).
  113. Peng, Y. L., Liu, Y. N., Liu, L., Wang, X., Jiang, C. L., Wang, Y. X. Inducible nitric oxide synthase is involved in the modulation of depressive behaviors induced by unpredictable chronic mild stress. Journal of Neuroinflammation. 9, (2012).
  114. Liu, B., et al. Icariin exerts an antidepressant effect in an unpredictable chronic mild stress model of depression in rats and is associated with the regulation of hippocampal neuroinflammation. Neuroscience. 294, 193-205 (2015).
  115. Yalcin, I., Aksu, F., Bodard, S., Chalon, S., Belzung, C. Antidepressant-like effect of tramadol in the unpredictable chronic mild stress procedure: Possible involvement of the noradrenergic system. Behavioural Pharmacology. 18 (7), 623-631 (2007).
  116. Mineur, Y. S., Belzung, C., Crusio, W. E. Functional implications of decreases in neurogenesis following chronic mild stress in mice. Neuroscience. 150 (2), 251-259 (2007).
  117. Simchon-Tenenbaum, Y., Weizman, A., Rehavi, M. Alterations in brain neurotrophic and glial factors following early age chronic methylphenidate and cocaine administration. Behav Brain Research. 282, 125-132 (2015).
  118. Hnasko, R. . ELISA: Methods and Protocols. , (2015).
  119. Watanabe, S. Social factors modulate restraint stress induced hyperthermia in mice. Brain Research. 1624, 134-139 (2015).
  120. Mineur, Y. S., Prasol, D. J., Belzung, C., Crusio, W. E. Agonistic behavior and unpredictable chronic mild stress in mice. Behaviour Genetics. 33 (5), 513-519 (2003).
  121. Frisbee, J. C., Brooks, S. D., Stanley, S. C., d'Audiffret, A. C. An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents. Journal of Visualized Experiments. (106), (2015).
  122. Westenbroek, C., Ter Horst, G. J., Roos, M. H., Kuipers, S. D., Trentani, A., Den Boer, J. A. Gender-specific effects of social housing in rats after chronic mild stress exposure. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 27 (1), 21-30 (2003).
  123. Bartolomucci, A., et al. Individual housing induces altered immuno-endocrine responses to psychological stress in male mice. Psychoneuroendocrinology. 28 (4), 540-558 (2003).
  124. Võikar, V., Polus, A., Vasar, E., Rauvala, H. Long-term individual housing in C57BL/6J and DBA/2 mice: Assessment of behavioral consequences. Genes, Brain and Behavior. 4 (4), (2005).
  125. Krohn, T. C., Sørensen, D. B., Ottesen, J. L., Hansen, A. K. The effects of individual housing on mice and rats: a review. Animal Welfare. 15 (4), 343-352 (2006).

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved